January 30, 2019
A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment
Read More
January 30, 2019
TMC435HPC3001 – An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy
Read More
December 10, 2018
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn’s Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy
Read More
December 10, 2018
Treatment of Microscopic Colitis
Read More
December 10, 2018
Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Read More
December 10, 2018
Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
Read More
December 10, 2018
A Study of TMC435 in Combination With Pegylated Interferon AlpFa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Read More
December 10, 2018
A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
Read More
X